首页> 外文期刊>Brain stimulation >A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease
【24h】

A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease

机译:每日左前额叶重复经颅磁刺激(rTMS)作为阿尔茨海默病辅助治疗的一例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Alzheimer's disease (AD) is the most common type of dementia. Current medication treatment is based on two main groups: anticholinesterases (IAChE) and NMDA receptor antagonists. These medications have demonstrated a symptomatic effect on certain cognitive and noncognitive symptoms of AD in the short term (6 months in most studies), although these effects are only limited.1'2 With diagnostic tools for AD becoming increasingly sophisticated, the pathology is identified at earlier stages than before,3 so suitable therapies must follow to limit the progression of the illness and the cognitive loss associated with it. We report the use of a noninvasive procedure, repetitive transcranial magnetic stimulation (rTMS), on cognitive symptoms of an AD patient.
机译:阿尔茨海默氏病(AD)是最常见的痴呆类型。当前的药物治疗基于两个主要类别:抗胆碱酯酶(IAChE)和NMDA受体拮抗剂。这些药物在短期内(大多数研究中为6个月)已证明对AD的某些认知和非认知症状有症状作用,尽管这些作用仅是有限的。1'2随着用于AD的诊断工具变得越来越复杂,病理得以识别在比以前更早的阶段3,必须采取适当的治疗措施,以限制疾病的进展和与之相关的认知障碍。我们报告了对AD患者的认知症状使用无创程序,重复经颅磁刺激(rTMS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号